gene and the heterogeneous nature of mutations, direct gene analysis often becomes difficult. 5, 6 Carrier screening and prenatal diagnosis of hemophilia A usually depend on haplotype analysis using restriction fragment length polymorphisms (RFLPs) and short tandem repeat (STR) markers to trace the defective FVIII gene within the family. Because the heterozygosity rates for different RFLPs differ ethnic groups, 7 it is important to have data on the informativity of various markers in different populations. We have examined the utility in carrier detection of 3 polymorphic sites at intron 18 (BclI), intron 19 (HindIII), and intron 22 (XbaI) in 100 patients with hemophilia A and their relatives at risk in north India.
Materials and Methods

Patients and Family Members
The study group included 100 patients with hemophilia A and 292 family members. The clinical diagnosis was based on detailed family history, physical examination, bleeding time, prothrombin time (PT), activated partial thromboplastin time (APTT), and Factor VIII bioassay. Confirmed patients and their H emophilia A is a common recessively inherited bleeding disorder caused by deficiency in blood coagulation factor FVIII, which is an essential component of the clotting cascade. 1 It is caused by mutations in the Factor VIII gene, of which inversion mutation of intron 22 accounts for about 45% of severe cases. 2 In India, with an estimated population of 1027 million, including 178 million 6 years of age or younger, 3 the number of hemophilia A patients is estimated to be 61 620 based on population frequency of 6 per 100 000. 4 Generally, FVIII replacement is the only therapeutic option for patients with hemophilia A, but in developing countries like India, cost constraint is a major problem. Preventing the birth of affected fetusus is the best present-day option to decrease the disease burden. Direct detection of mutations may be the best choice for carrier detection and prenatal diagnosis; however, due to the size and complexity of the FVIII Health schemes are promoting application of molecular diagnosis and screening in peripheral diagnostics labs. Intragenic restriction fragment length polymorphisms in the intron 18 (BclI), intron 19 (HindIII), and intron 22 (XbaI) of the Factor VIII gene were studied in 100 patients with hemophilia A and their relatives at risk from different regions of north India. For BclI, HindIII, and XbaI, the positive allele frequency was 0.57, 0.38, and 0.43, respectively, and heterozygosity was 0.54, 0.49, 0.41, respectively, whereas the heterozygosity in terms of informativity of the above markers was 53% for BclI, 44% for HindIII, and 34% for XbaI. Combined informativity of these markers was 77%. Review of Indian and world literature shows a marked variation in the informativity of polymorphic sites. Screening for carriers forms the baseline for prevention of hemophilia A. Polymerase chain reaction-restriction fragment length polymorphism is a low-cost procedure, efficient in the north Indian population. Keywords: hemophilia A; polymorphism; RFLP; BclI; XbaI; HindIII; carrier detection families were selected for molecular analysis. A positive family history of disease was identified in 48%. Sixty-one women included in the study were obligate carriers, whereas 137 were suspected carriers.
Severity of Disease
Fresh plasma was collected, and PT, APTT, and FVIII assays were carried out in all cases of hemophilia. On the basis of the FVIII levels, 54 of 100 patients were diagnosed with severe hemophilia (<1% FVIIIC), 42 with moderately severe hemophilia (1%-5% FVIIIC), and 4 with mild hemophilia (1%-5% FVIIIC).
Deoxyribonucleic Acid Extraction
In 0.5 M ethylenediamine tetraacetic acid, 5 to 10 mL of peripheral blood was collected from patients and their family members with prior informed consent. Deoxyribonucleic acid was extracted by using the standard phenol chloroform method. 8
Polymerase Chain Reaction
Three intragenic markers-BclI, HindIII, and XbaI-were analyzed in the study. Polymerase chain reaction (PCR) was performed in a progene thermocycler (Techne, Cambridge, UK) using thin-walled tubes according to protocol developed by Kogan et al 9 and Graham et al 10 , with some modifications. For HindIII, a new primer design was used. The final volume of 20 µL contained 250 ng genomic deoxyribonucleic acid, 10 pM of forward and reverse primers in reaction mixture at a concentration of 1×, 10 mM each of deoxyribonucleotide triphosphates, and 1 unit of Taq polymerase. Amplification was carried out for 30 cycles using the following primers: BclI 9 -forward primer: GTGAGTAGCAGTGTGG-GCAGA; reverse primer: CTGAAATGAAACGGGTG-GAAC; HindIII (newly designed primer)-forward primer: TAAAAGCCTTTAAATGGTCTAGGC; reverse primer: TTCGAATTCTGAAATTATCTTGTTC; XbaI 9 -forward primer: CACGAGCTCTCCATCTG-AACATG; reverse primer: GGGCTGCAGGGGG-GGGGACAACAG.
Primer Design
Our oligonucleotide primer for HindIII was designed by using primer analysis software (Oligo Primer Analysis Software, Version 6.71; Molecular Biology Insights, Cascade, CO). The melting temperature of the primers was calculated using the programs Oligo calculator based on percent guanine-cytosine content.
Digestion and Electrophoresis
Ten microliters of PCR product was digested overnight at 55°C for BclI (New England Biolabs, Herts, UK) and 37°C for HindIII (Bangalore Genei, Bangalore, India) and XbaI (New England Biolabs, Ipswich, MA). These digested products were electrophoresed on 2.5% agarose for HindIII, 10% polyacrylamide gel electrophoresis (PAGE) for BclI, and 12% PAGE for XbaI. Alleles were assigned according to presence or absence of restriction site; haplotype analysis of each family was constructed according to positive and negative alleles.
Statistical Analysis
The gene frequencies were calculated on the basis of X chromosomes studied. The expected heterozygote frequency was calculated by using Hardy-Weinberg principle.
Results
BclI PCR-RFLP
Fifty-three of 100 families were informative, and 24 of 53 suspected carriers could be diagnosed by this technique. The observed heterozygosity and allele frequencies are shown in Table 1 . The expected frequency of heterozygosity was 0.50, and observed frequency of heterozygosity was 0.54 ( Figure 1 ).
HindIII PCR-RFLP
Forty-four of 100 families were informative, and 23 of 53 suspected carriers could be diagnosed by this technique. The observed heterozygosity and allele frequencies are shown in Table 1 . The expected frequency of heterozygosity was 0.48, and observed frequency of heterozygosity was 0.49 ( Figure 2 ).
XbaI PCR-RFLP
Thirty-four of 100 families were informative, and 16 of 53 suspected carriers could be diagnosed by this technique. The observed heterozygosity and allele frequencies are shown in Table 1 . The expected frequency of heterozygosity was 0.50, and observed frequency of heterozygosity was 0.41 ( Figure 3 ).
Informativity of BclI, HindIII, and XbaI was 0.53, 0.44, and 0.34, respectively, and the positive allele frequency of BclI, HindIII, and XbaI was 0.57, 0.38, and 0.43, respectively (Table 1) . Analysis was done for frequency of positive and negative alleles, expected and observed frequencies of heterozygosity, and the observed heterozygosity in terms of informativity. The combined informativity of the 3 RFLP markers was 77%.
Discussion
Data from the current study suggest that BclI is highly informative, followed by HindIII and XbaI in the north Indian population. Using a combination of the 3 informative polymorphisms, carriers would be identified in 77% of families. There was a considerable allelic association between BclI and HindIII markers, 35 of 53 families with hemophilia A being informative by both tests (Figure 4 ). Additional information was provided only for 9 families by adding HindIII. XbaI was informative in 34 families, and 16 of these also showed polymorphism at the BclI site. Thus, 18 families were additionally diagnosed by adding the XbaI polymorphism. Allelic association between BclI and HindIII has been reported in most populations and reaches 83% in African Americans. 10 The positive allele is more frequent in most populations worldwide, except in African Americans, 10 where the negative allele is present. A review of Indian reports and this study showed that the positive allele frequencies of BclI, HindIII, and XbaI were 0.50, 0.34, and 0.51, and negative allele frequencies were 0.50, 0.66, and 0.49, respectively [11] [12] [13] [14] [15] (Table 2) . A comprehensive review of allelic distribution and frequency of heterozygosity rates in populations worldwide is detailed in Table 3 . The order in which the polymorphisms should be tested would vary by race and country. In India, a review of the literature suggests screening for BclI followed by XbaI and HindIII. TaqI RFLP showed a high heterozygosity of up to 86% in India, 11 but being an extragenic marker, occasional recombination can confound results. STR markers in introns 13 and 22 in other Indian studies show heterozygosity of 0.54 and 0.45, respectively. 12, 14, 15 Polymorphism-based gene tracking has inherent limitations due to mosaicism, disputed paternity, and new mutations affecting site.
The simplicity of the PCR-RFLP test and its capacity for implementation in peripheral laboratories with low infrastructure costs make it a suitable screening procedure. Because routine mutation analysis in the 26 exons of the hemophilia A gene cannot practically be adopted as a procedure to diagnose and characterize families, PCR-RFLP is here to stay. 
